Literature DB >> 18477883

Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months.

Heather E McNeely1, Helen S Mayberg, Andres M Lozano, Sidney H Kennedy.   

Abstract

The purpose of this study was to evaluate preservation of cognitive function after deep brain stimulation (DBS) of the subgenual cingulate (Cg25) for treatment-resistant depression (TRD). We have previously reported on the treatment methods, safety, and 6-month clinical outcome (Mayberg et al., Neuron. 2005;45:651-660). Comprehensive neuropsychological assessments tapping 4 domains of frontal lobe function, and general cognitive abilities, were completed before implantation and at 3, 6, and 12 months postonset of continuous DBS in 6 TRD patients. No adverse neuropsychological effects were noted following surgery, onset and maintenance of DBS with the exception of transient motor slowing noted at 3 and 6 months that improved to normative levels by 12 months. Several areas of cognition that were below average or impaired at baseline improved over follow-up, and these changes were not correlated with improvements in mood. Though the sample size is small, these results support cognitive safety of Cg25 DBS for TRD.

Entities:  

Mesh:

Year:  2008        PMID: 18477883     DOI: 10.1097/NMD.0b013e3181710927

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  24 in total

1.  Tractographic analysis of historical lesion surgery for depression.

Authors:  Jan-Christoph Schoene-Bake; Yaroslav Parpaley; Bernd Weber; Jaak Panksepp; Trevor A Hurwitz; Volker A Coenen
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 2.  Brain stimulation in psychiatry and its effects on cognition.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

3.  Advances in the Management of Treatment-Resistant Depression.

Authors:  Paul E Holtzheimer
Journal:  Focus (Am Psychiatr Publ)       Date:  2010

Review 4.  Closed-loop neuromodulation systems: next-generation treatments for psychiatric illness.

Authors:  Meng-Chen Lo; Alik S Widge
Journal:  Int Rev Psychiatry       Date:  2017-02-10

5.  Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy.

Authors:  Bettina H Bewernick; Sarah Kayser; Volker Sturm; Thomas E Schlaepfer
Journal:  Neuropsychopharmacology       Date:  2012-04-04       Impact factor: 7.853

6.  Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression.

Authors:  Jared L Moreines; Shawn M McClintock; Mary E Kelley; Paul E Holtzheimer; Helen S Mayberg
Journal:  Depress Anxiety       Date:  2014-04-17       Impact factor: 6.505

7.  Regional electric field induced by electroconvulsive therapy in a realistic finite element head model: influence of white matter anisotropic conductivity.

Authors:  Won Hee Lee; Zhi-De Deng; Tae-Seong Kim; Andrew F Laine; Sarah H Lisanby; Angel V Peterchev
Journal:  Neuroimage       Date:  2011-10-18       Impact factor: 6.556

Review 8.  Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes.

Authors:  Takashi Morishita; Sarah M Fayad; Masa-aki Higuchi; Kelsey A Nestor; Kelly D Foote
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 9.  Deep brain stimulation for psychiatric disorders.

Authors:  Jens Kuhn; Theo O J Gründler; Doris Lenartz; Volker Sturm; Joachim Klosterkötter; Wolfgang Huff
Journal:  Dtsch Arztebl Int       Date:  2010-02-19       Impact factor: 5.594

Review 10.  Deep brain stimulation of the human reward system for major depression--rationale, outcomes and outlook.

Authors:  Thomas E Schlaepfer; Bettina H Bewernick; Sarah Kayser; Rene Hurlemann; Volker A Coenen
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.